Full‐dose challenge of moderate, severe, and unknown beta‐lactam allergies in the emergency department
Academic Emergency Medicine · 2024
DOI: 10.1111/acem.14893 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Emergency Medicine, 2024. Verfasst von Adam M Anderson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Grand River Emergency Medical Group, Grand Rapids, Michigan, USA. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Emergency Service, Hospital, beta-Lactams, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Objective
This study aims to assess the outcome of challenging documented moderate, severe, or unknown beta‐lactam allergies with full dose administration of a beta‐lactam antibiotic in emergency department (ED) patients admitted for acute bacterial infection.
Methods
A single‐center, retrospective, descriptive study of adult patients challenged with a full dose of beta‐lactam in the ED from January 2021 to December 2022 was conducted. Included patients had at least one documented moderate, severe, or unknown beta‐lactam allergy in the electronic medical record (EMR) without documentation of prior tolerance. Patient demographics, prior beta‐lactam antibiotic reaction, beta‐lactam administered in the ED, inpatient beta‐lactam continuation, adverse drug reactions, and updates to allergy profiles were collected. Descriptive statistics for data analysis were performed using SPSS Version 22.
Results
Of the 184 ED encounters with full‐dose beta‐lactam challenges, five (2.7%) patients with documented moderate, severe, or unknown beta‐lactam allergies experienced an allergic reaction after the challenge; one (0.5%) patient had an allergic reaction in the ED, and the remaining four (2.2%) occurred after admission. No anaphylactic reactions occurred. All allergic reactions were limited to mild rash or itching. Most patients (98.9%) were challenged with a cephalosporin. A beta‐lactam was continued in 86.4% of cases, and the allergy profile was updated for future utilization in 73.4% of patients.
Conclusions
This study suggests that full‐dose challenge of moderate, severe, or unknown beta‐lactam allergies can be safely accomplished in the ED. This approach avoids unnecessary penicillin allergy skin testing and reduces utilization of suboptimal alternative antibiotic regimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grand River Emergency Medical Group, Grand Rapids, Michigan, USA.
- Trinity Health-West Michigan Emergency Medicine Residency, Muskegon, Michigan, USA.
- Department of Pharmacy, Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan, USA.
ORCID-Profile: Reid E Mitchell
Zitieren
APA
Anderson, A. M., Coallier, S., Mitchell, R. E., Dumkow, L. E., & Wolf, L. M. (2024). Full‐dose challenge of moderate, severe, and unknown beta‐lactam allergies in the emergency department. Academic Emergency Medicine. https://doi.org/10.1111/acem.14893
Vancouver
Anderson AM, Coallier S, Mitchell RE, Dumkow LE, Wolf LM. Full‐dose challenge of moderate, severe, and unknown beta‐lactam allergies in the emergency department. Academic Emergency Medicine. 2024. doi:10.1111/acem.14893
BibTeX
@article{Anderson2024,
author = {Anderson, Adam M and Coallier, Stephanie and Mitchell, Reid E and Dumkow, Lisa E and Wolf, Lauren M},
title = {Full‐dose challenge of moderate, severe, and unknown beta‐lactam allergies in the emergency department},
journal = {Academic Emergency Medicine},
year = {2024},
doi = {10.1111/acem.14893}
}
EUVIMED